For cost-effective cures, the drug pricing policy challenge is not simply to lower prices, but also to spread the drug costs among payers.
Erin C. Fuse Brown, JD, MPH
Advertisement
Articles by Erin C. Fuse Brown, JD, MPH
Advertisement
Latest Updated Articles
- The Challenge of Paying for Cost-Effective Cures
Published: January 17th 2017 | Updated:
Advertisement
Advertisement
Trending on AJMC
1
New Legislation Aims to Address Transparency in PBMs as First Major Step in Reform
2
FDA to Restrict Ingredients Used in Mass-Marketed Compounded GLP-1s, Crack Down on Misleading Ads
3
Overcoming Mistrust in Clinical Trial Enrollment Through Community Resources: Susan Vadaparampil, PhD, MPH
4
Catchment Areas Shape Diversity and Access in Oncology Trials: Amir Fathi, MD
5